pCR Rates Following Neoadjuvant Therapy Similar Between Black and White Women With Breast Cancer
Findings from a breast cancer analysis demonstrated that pathologic complete response and event-free survival rates were not significantly affected by patient’s race.
Merry and Bright: Bringing a Festive Air into the Oncology Space for the Holidays
In this episode of “The Vitals,” 2 health care professionals discuss how to safely celebrate the holidays in oncology units.
Myeloproliferative Neoplasms in Accelerated Phase Continue to Present as Treatment Challenge
Treating patients with myeloproliferative neoplasms in accelerated phase (MPN-AP) remains an ongoing challenge as there are still no standard therapeutic approaches, says an expert.
Personalized Screenings are Needed to Address Racial Disparities in Breast Cancer Outcomes
“We want to make sure we can provide the right treatment for the right patient at the right time,” says Olufunmilayo I. Olopade, MD, FACP, OON.
More Immunotherapy May Enter TNBC Space
Nearly 1 year following the first checkpoint inhibitor approval in advanced triple-negative breast cancer, additional immunotherapeutic agents are poised to enter the field, according to Rita Nanda, MD.
Pollack Discusses Ongoing Research for Patients With Refractory mCRC and Other Hard-to-Treat GI Malignancies
Pollack Offers Perspective on 2023 ASCO GI Cancers Symposium
Nivolumab/Cabozantinib Shows Continued Benefit In Frontline Treatment of RCC
Goodman Highlights Potential Benefit of SBRT in Locally Advanced Pancreatic Cancer
